PRTA - Prothena Corporation plc logo

PRTA

Prothena Corporation plc

Prothena Corporation plc is a biotechnology company focused on developing therapies targeting protein dysregulation for neurodegenerative diseases like Alzheimer's and Parkinson's. Its pipeline includes investigational antibodies in various clinical trial phases.

⚕️ Healthcare NASDAQ Listed 2012 $ USD
$1,000 invested 10 years ago $160today

Score Overview

1 Year
Score
Net Growth81.98%
Net TrendGrew
Net Income Consistency
Rev Growth463.09%
Rev TrendGrew
Revenue Consistency
5 Years
Score3.0
Net Growth-165.68%
Net Trend40%
Net Income Consistency
Rev Growth-72.81%
Rev Trend60%
Revenue Consistency
10 Years
Score
Net Growth72.52%
Net Trend50%
Net Income Consistency
Rev Growth51x
Rev Trend60%
Revenue Consistency
All Time
Score
Net Growth-6.23%
Net Trend50%
Net Income Consistency
Rev Growth20x
Rev Trend50%
Revenue Consistency

See the full market ranking →

Prothena Corporation plc fundamental performance

Between 2020 and 2025, revenue grew from $ 853K to $ 9M and net income went from -$ 111M to -$ 244M. Revenue increased in 3 of those 5 years; net income in 2.

Between 2015 and 2025, revenue grew from $ 1M to $ 9M and net income went from -$ 80M to -$ 244M. Revenue increased in 6 of those 10 years; net income in 5.

Prothena Corporation plc currently holds a 5-year HDB Score of 3.0 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 9.26
1 Year2025-08-12
$ 7.5422.81%
5 Years2021-08-12
$ 58.79-84.25%
10 Years2016-08-12
$ 57.79-83.98%
All Time2012-12-21
$ 7.2028.61%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 54M-$ 43M$ 288M
2025$ 9M-$ 244M$ 307M
2024$ 135M-$ 122M$ 471M
2023$ 91M-$ 147M$ 618M
2022$ 53M-$ 116M$ 710M
2021$ 200M$ 66M$ 579M
2020$ 853K-$ 111M$ 295M
2019$ 814K-$ 77M$ 375M
2018$ 955K-$ 155M$ 427M
2017$ 27M-$ 153M$ 417M
2016$ 1M-$ 160M$ 386M
2015$ 1M-$ 80M$ 370M
2014$ 50M-$ 7M$ 293M
2013$ 676K-$ 40M$ 176M
IPO2012$ 2M-$ 41M$ 124M

Explore beyond PRTA

You're looking at Prothena Corporation plc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies